|Dr. Benjamin J. Lipps||Chairman of the Management Board & CEO||N/A||N/A||1940|
|Mr. Christian Von Volkmann M.B.A., MBA||CFO & Member of Management Board||N/A||N/A||1971|
|Dr. Andreas Jordan||Exec. VP, Chief Scientific Officer & MD of Europe||N/A||N/A||1959|
|Ms. Barbara Von Frankenberg||VP of Communications & Investor Relations||N/A||N/A||N/A|
|Ms. Solveig Salomon||VP of Marketing & Sales and European Commercial Director||N/A||N/A||N/A|
|Dr. Hans Joachim Hutt M.D., Ph.D.||Medical Consultant||N/A||N/A||N/A|
MagForce AG operates in the field of nanotechnology-based cancer therapy in Germany and Poland. It offers NanoTherm, a therapy for the treatment of brain tumors; NanoPlan, a software that supports the attending physician in preparing the ideal treatment plan for the NanoTherm therapy; and NanoActivator, a magnetic field generator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.
MagForce AGs ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.